Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks' gestation and preeclampsia: a case-control study (Q82895915)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks' gestation and preeclampsia: a case-control study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

A A Khalil

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

D Tsikas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

R Akolekar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J Jordan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

K H Nicolaides

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

8 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

38-43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158463%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/jhh.2011.109

18 January 2020

exact match

0 references

cites work

Gene expression of nitric oxide synthase in cultured human term placental trophoblast during in vitro differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Hepatocyte growth factor induced human trophoblast motility involves phosphatidylinositol-3-kinase, mitogen-activated protein kinase, and inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Participation of the Mouse Implanting Trophoblast in Nitric Oxide Production During Pregnancy1

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

On the substrate specificity of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Endogenous nitric oxide synthase inhibitors are responsible for the L -arginine paradox

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Levels of dimethylarginines and cytokines in mild and severe preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Reduced L-arginine level and decreased placental eNOS activity in preeclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

De novo synthesis of trideuteromethyl esters of amino acids for use in GC-MS and GC-tandem MS exemplified for ADMA in human plasma and urine: standardization, validation, comparison and proof of evidence for their aptitude as internal standards

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

The frequency and severity of placental findings in women with preeclampsia are gestational age dependent

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Is pre-eclampsia more than one disease?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Adiponectin and insulin resistance in early- and late-onset pre-eclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Soluble endoglin contributes to the pathogenesis of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Endoglin in angiogenesis and vascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Cochrane Database of Systematic Reviews

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

A critical review and discussion of analytical methods in the L-arginine/nitric oxide area of basic and clinical research

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Homoarginine, cardiovascular risk, and mortality

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

Stimulus-secretion coupling of arginine-induced insulin release. Uptake of metabolized and nonmetabolized cationic amino acids by pancreatic islets

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021

An L-arginine/nitric oxide pathway present in human platelets regulates aggregation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.109

7 January 2021